Physician profile
Michael Cheng
NPI 1942303276
$9,916.15
in general payments reported to CMS, 2019-2025
25 companies · $1,457 in 2025
The $1,457 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $251 · 2021: $263 · 2022: $492 · 2023: $726 · 2024: $6,339 · 2025: $1,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,300 · Food and Beverage: $3,384 · Travel and Lodging: $743 · Education: $95.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,300.00 |
| Food and Beverage | $3,383.58 |
| Travel and Lodging | $743.04 |
| Education | $95.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $5,703.02 | 2024-2025 | Voquezna |
| Abbvie INC. | $1,254.44 | 2019-2025 | Skyrizi, Rinvoq, Viberzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $528.14 | 2020-2025 | Xifaxan, Plenvu, Trulance |
| Boston Scientific Corporation | $348.09 | 2024-2025 | Apollo Esg System, Exalt Model D, Resolution 360 Clip |
| Janssen Biotech, INC. | $292.43 | 2019-2025 | Tremfya, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $287.09 | 2019-2025 | Entyvio, Eohilia |
| Braintree Laboratories, INC. | $257.84 | 2019-2021 | |
| Qol Medical, LLC | $219.21 | 2023-2024 | Sucraid, Sucraid |
| Regeneron Healthcare Solutions, INC. | $167.05 | 2024-2025 | Dupixent |
| Ipsen Biopharmaceuticals, INC | $144.35 | 2023-2025 | Iqirvo, Bylvay |
| Gilead Sciences, INC. | $116.04 | 2020-2022 | |
| Lilly USA, LLC | $103.23 | 2024-2025 | Omvoh |
| Pfizer INC. | $70.68 | 2023-2025 | |
| Genzyme Corporation | $67.91 | 2024-2025 | |
| Madrigal Pharmaceuticals | $49.92 | 2024-2025 | Rezdiffra, Resmetirom |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $49.20 | 2023-2024 | Dificid |
| Aimmune Therapeutics, INC. | $45.76 | 2025 | Zenpep |
| Ironwood Pharmaceuticals, INC | $40.87 | 2023-2024 | Linzess |
| Redhill Biopharma INC. | $36.46 | 2021 | |
| Intercept Pharmaceuticals, INC. | $33.08 | 2019-2020 | |
| Merz North America, INC. | $31.86 | 2020 | |
| Allergan, INC. | $24.37 | 2019 | |
| Organon LLC | $21.49 | 2024 | |
| Glaxosmithkline, LLC. | $13.14 | 2022 | |
| Janssen Pharmaceuticals, INC | $10.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.